Italian CRO OPIS: The ideal 바카라 꽁머니 사이트 partner for Korean pharmaceutical and biotech companies beyond Europe

[by Kang, In Hyo] “OPIS’ primary goal is to support 바카라 꽁머니 사이트 services that drive the growth of Korea’s pharmaceutical and biotechnology industries while offering strategic guidance to help Korean companies succeed in the global market.”

Giovanni Trolese, vice president of strategic development at 바카라 꽁머니 사이트, shared this vision during an interview with <THE BIO at the ‘2025 J.P. Morgan Healthcare Conference,’ the world’s largest pharmaceutical and biotechnology investment event held in San Francisco, USA, last month.

Founded in 1988 in Italy by a group of medical doctors, OPIS has grown into a global 바카라 꽁머니 사이트 trial contract research organization (CRO) with 18 offices around the world. Alongside its headquarters in Italy, the company operates offices across Europe, including locations in Switzerland, Spain, Germany, France, Belgium, the UK, the Netherlands, Sweden, Poland, Hungary, Serbia, and Bulgaria. Additionally, it has expanded to Boston in the United States, Sydney in Australia, and key markets in Asia, such as Korea, Japan, and Taiwan. OPIS established its Korean branch, OPIS KOREA, in April 2022.

“OPIS has solidified its position as a global CRO by successfully managing over 1,500 바카라 꽁머니 사이트 projects in collaboration with multinational pharmaceutical companies,” Trolese emphasized. “OPIS KOREA consists of Korean professionals with international expertise and continues to expand by refining its 바카라 꽁머니 사이트 research capabilities in Korea.”

OPIS is a global CRO that provides comprehensive support to pharmaceutical and biotech companies throughout all phases of 바카라 꽁머니 사이트 research. Its services range from research concept creation and protocol development to full project execution, study data handling, research analysis, and reporting. The company ensures seamless trial execution and strict regulatory compliance throughout 바카라 꽁머니 사이트 trials across all phases of new drug development, providing efficient and precise 바카라 꽁머니 사이트 performance.

OPIS specializes in multiple therapeutic areas, with strengths in oncology, neuroscience, cardiovascular diseases, and rare diseases. Among its 바카라 꽁머니 사이트 trials, the largest share of its projects dominates in phase 3 바카라 꽁머니 사이트 trials, making up 40% of its trials. Phase 2 trials make up 29%, followed by phase 4 at 16% and phase 1 at 11.5%. This distribution underscores OPIS’ competitive advantage in late-stage 바카라 꽁머니 사이트 trials compared to early-phase studies.

Trolese highlighted that OPIS offers a full spectrum of 바카라 꽁머니 사이트 trial services, spanning from Phase 1 to Phase 4. OPIS ensures the success of 바카라 꽁머니 사이트 trials for pharmaceutical companies and biotech companies by integrating medical expertise into its operations. Trolese explained that OPIS is a global CRO that provides full-service support, expertly managing 바카라 꽁머니 사이트 studies at every stage.

“OPIS provides tailored, comprehensive 바카라 꽁머니 사이트 solutions for pharmaceutical, biotechnology, and medical device companies. Our goal is to support customers’ needs throughout the entire 바카라 꽁머니 사이트 development process, from early-stage consulting to post-marketing research,” Trolese said.

“We are strengthening our brand in key regions, including Europe, North America, Asia, and the Middle East,” he further commented. “Through continued expansion, we are establishing OPIS as a trusted 바카라 꽁머니 사이트 trial partner for pharmaceutical and biotech companies worldwide.”

As part of its expansion strategy, 바카라 꽁머니 사이트 plans to open two new branches next year, bringing its total global presence to 20 locations. “This year, our primary focus will be on consolidating and strengthening the operations of our existing clients. Maintaining a strong industry position remains our top priority, allowing us to deliver even better results for our clients,” Trolese remarked.

This year, OPIS is focusing on expanding its ‘Drug Development Consulting Team’ to further strengthen its medical and scientific expertise in new drug development. Through this, OPIS aims to offer end-to-end support to pharmaceutical and biotechnology companies throughout the entire 바카라 꽁머니 사이트 development process, ensuring access to a wide range of expertise to drive the success of each project.

“We are actively developing two additional software tools,” Trolese expressed. “These will be released by the end of this year to streamline 바카라 꽁머니 사이트 trial management, improve data analysis, and increase operational efficiency.”

OPIS, a global CRO offering full-service 바카라 꽁머니 사이트 trials, also develops and operates advanced digital solutions to improve 바카라 꽁머니 사이트 trial efficiency, data handling, and regulatory compliance. One such solution is OPIS’ proprietary electronic data capture (EDC) system, ‘바카라 꽁머니 사이트.net (www.바카라 꽁머니 사이트.net),’ a web-based platform designed to meet the highest regulatory standards while offering an intuitive and user-friendly interface.

“바카라 꽁머니 사이트.Net is fully compliant with Good 바카라 꽁머니 사이트 Practice (GCP) guidelines and the U.S. Food and Drug Administration’s (FDA) 21 CFR Part 11 regulations. Our Information and Communication Technology (ICT) department ensures continuous maintenance, updates, and support for the system,” Trolese explained.

The FDA’s ‘21 CFR (Code of Federal Regulations) Part 11 regulations mandate strict data integrity and security standards for electronic records and electronic signatures, ensuring reliability throughout the 바카라 꽁머니 사이트 trial, manufacturing, and quality control processes.

“바카라 꽁머니 사이트.Net is built to safely gather and oversee data from ‘ePRO (electronic patient report)’ and ‘eCOA (electronic 바카라 꽁머니 사이트 outcome assessment)’ across multiple platforms,” Trolese further commented.

According to Trolese, at this year’s J.P. Morgan Healthcare Conference, 바카라 꽁머니 사이트 conducted 200 meetings, with its five-member global team averaging 40 meetings each.

“Our goal was to expand our global network, explore new business opportunities, and identify potential collaborations,” Trolese stated. “Through this, we have reinforced our position as a strategic partner for pharmaceutical and biotech companies seeking high-quality 바카라 꽁머니 사이트 research solutions.”

Looking ahead, Trolese reaffirmed OPIS’s commitment to maintaining its reputation as a trusted partner in the evolving CRO landscape while upholding excellence in 바카라 꽁머니 사이트 operations management quality.

“As a global CRO, OPIS aims to build a strong and reliable presence in the Korean 바카라 꽁머니 사이트 market, ensuring high-quality service delivery across all operations,” he said. “To this end, OPIS KOREA continues to work closely with our headquarters while steadily growing.

“OPIS KOREA will proactively support Korean companies by offering tailored 바카라 꽁머니 사이트 solutions to facilitate their entry into the global market, ensuring compliance with regulatory standards, and optimizing the development process to enable seamless execution of global 바카라 꽁머니 사이트 trials,” Trolese stressed. “We will make every effort to support the growth of the Korean pharmaceutical industry and help extend their footprint internationally.”